AR |
Astragali radix |
BB |
Bioavailability barrier |
DMEs |
Drug-metabolizing enzymes |
ETs |
Efflux transporters |
HPGPC |
High-performance gel-permeation chromatography |
GC |
Chromatography |
NF-κB |
Nuclear factor-kappa B |
TLR4 |
Toll-like receptor 4 |
PGC-1α |
Peroxisome proliferator-activated receptor-γ coactivator 1 α |
NFATc3 |
Nuclear factor of activated T cell scytoplasmic 3 |
CaMKII |
Calmodulin II kinase |
SERCA2a |
Sarcoplasmic reticulum Ca2+-ATPase |
PPARα |
Proliferator-activatedαreceptor |
α-SMA |
α-smooth muscle actin |
ECM |
Extracellular matrix |
Col-1 |
Colgen I |
TRPM |
Transient receptor potential channel |
TRPC6 |
Transient receptor potential channel 6 |
ROS |
Reactive oxygen species |
CT-1 |
Cardiotrophin-1 |
HO-1 |
Heme oxygenase-1 |
NQO1 |
NAD(P)H dehydrogenase (quinone) 1 |
Nrf2 |
Nuclear factor-erythroid 2-related factor 2 |
LPS |
Lipopolysaccharide |
tBHP |
Tert-butyl hydroperoxide |
SOD |
Superoxide dismutase |
CHD |
Coronary heart disease |
NOD |
Non-obese diabetic |
gal-1 |
Galectin-1 |
Glut4 |
Glucose transporter 4 |
AMPK |
AMP-activated protein kinase |
PKB |
Protein kinase B |
PTP1B |
Protein tyrosine phosphatase 1B |
ER |
Endoplasmic reticulum |
ATF6 |
Transcription activator 6 |
MOMP |
Mitochondrial extracorporeal membrane permeability |
PPAR |
Peroxisome proliferator-activated receptor |
MCP-1 |
Monocyte chemotactic protein-1 |
ICAM-1 |
Intercellular adhesion molecule-1 |
iNOS |
Inducible nitric oxide synthase |
EMT |
Epithelial-mesenchymal transition |
STZ |
Streptozotocin |
IGF1 |
Insulin-like growth factor 1 |
PI3K |
Phosphatidylinositol3-kinase |
Akt |
Protein kinase B |
GRP78 |
Glucose-regulated protein 78 |
FasL |
Fas ligand |
HDAC5 |
Histone deacetylase 5 |
CAV-1 |
Caveolin-1 |
TGF-β |
Transforming growth factor-β |
ECM |
Extracellular matrix |
LDHA |
Lactate dehydrogenase A |
TIGAR |
TP53-induced glycolysis and apoptosis regulator |
MAPK |
Mitogen-activated protein kinase |
ERK |
Extracellular signalregulated kinase |
TNF |
Tumor necrosis factor |
IFN |
Interferon |
KMT2D |
Histone-lysine N-methyltransferase 2Dlysine (K) -specific methyltransferase 2D |
CREBBP |
CREB binding protein |
Foxo3a |
Forkhead box O transcription factor 3a |
BIP |
Binding immunoglobulin protein |
CHOP |
Chomologous protein |
EGFL7 |
Epidermal growth factor-like domain 7 |
HK-II |
Hexokinase-II |
mPTP |
Mitochondrial permeability transition pore |
PD |
Parkinson’s disease |
TH |
Tyrosine hydroxylase |
MPTP |
1-methyl-4-phenyl-1 |
6-OHDA |
6-hydroxydopamine |
IRS1 |
Insulin receptor substrate 1 |
APS |
Astragalus Polysaccharides |
AS-IV |
Astragaloside IV |
ISO |
Isoproterenol |
CG |
Calycosin-7-β-glucoside |
C-3′-G |
Calycosin-3′-glucuronide |
CG-3′-G |
CG-3′-glucuronide |
F-7-G |
Formononetin-7-glucuronide |
D-7-G |
Daidzein-7-glucuronide |
CYPs |
Cytochromes P450 |
SULT |
sulfotransferase |
GST |
GlutathioneS-transferase |
UGT |
Uridine 5′-diphospho (UDP)-glucuronosyltransferase |
NATs |
N-acetyltransferases |
P-gp |
P-glycoprotein |
MRP2 |
Multidrug resistance-associated protein 2 |
BCRP |
Breast cancer resistance protein |
MRPs |
Multidrug resistance-related proteins |
OATs |
Organic anion transporters |
SGLT-1 |
Sodium-dependent glucose transporter 1 |
BSβG |
Broad-specific β-glucuronides |
LPH |
Lactase phlorizin hydrolase |
Bra B |
Brachyoside B |
Cyc B |
Cyclogaleginoside B |
CA |
Cycloastragenol |
iso-CA |
Iso-cycloastragenol |
CA-2H |
Dehydrogenated metabolite of CA |
AUC |
Area under the curve |
T1/2
|
Elimination half-life |
CL |
Clearance |
Vd
|
Apparent volume of distribution |
MRT |
Mean residence time |